These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 8951217)
21. Gene expression patterns as predictive biomarkers in hematology-oncology: principal hurdles on the road to the clinic. Rázga F; Némethová V Haematologica; 2017 Jan; 102(1):e31-e32. PubMed ID: 28040789 [No Abstract] [Full Text] [Related]
24. Integrating predictive biomarkers and classifiers into oncology clinical development programmes. Beckman RA; Clark J; Chen C Nat Rev Drug Discov; 2011 Sep; 10(10):735-48. PubMed ID: 21959287 [TBL] [Abstract][Full Text] [Related]
25. [Which future for B lymphocytes infiltrating solid tumors: prognostic biomarker and/or therapeutic target?]. Kaplon H; Dieu-Nosjean MC Med Sci (Paris); 2018 Jan; 34(1):72-78. PubMed ID: 29384099 [TBL] [Abstract][Full Text] [Related]
26. [New perspectives in cancer treatment]. Brugarolas A; Giráldez J Rev Med Univ Navarra; 1998; 42(3):127-33. PubMed ID: 10420935 [No Abstract] [Full Text] [Related]
27. Deal-making trends in oncology. Moore K; Walker J Nat Rev Drug Discov; 2009 Aug; 8(8):604. PubMed ID: 19644466 [No Abstract] [Full Text] [Related]
28. Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine. Benz MR; Vargas HA; Sala E Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):1-10. PubMed ID: 26613872 [TBL] [Abstract][Full Text] [Related]
29. The impact of molecular pathology in oncology: the clinician's perspective. Grade M; Becker H; Ghadimi BM Cell Oncol; 2004; 26(5-6):275-8. PubMed ID: 15623937 [No Abstract] [Full Text] [Related]
30. MR Imaging Pushes Radiologists to Move Forward in Oncologic Imaging. Luna A Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):xvii-xviii. PubMed ID: 26613887 [No Abstract] [Full Text] [Related]
31. [Tumor heterogeneity has considerable importance for the oncology practice]. Versicherungsmedizin; 2013 Mar; 65(1):52-3. PubMed ID: 23593823 [No Abstract] [Full Text] [Related]
32. Abstracts of the 13th World Congress on Advances in Oncology and the 11th International Symposium on Molecular Medicine, 9-11 October 2008, Crete, Greece. Int J Mol Med; 2008; 22 Suppl 1():S5-91. PubMed ID: 18939316 [No Abstract] [Full Text] [Related]
33. Abstracts of the 11th World Congress on Advances in Oncology and the 9th International Symposium on Molecular Medicine, 12-14 October 2006, Hersonissos, Greece. Int J Mol Med; 2006; 18 Suppl 1():S5-86. PubMed ID: 17315337 [No Abstract] [Full Text] [Related]
34. Conference scene: biomarkers in the field of oncology. Warford A Biomark Med; 2011 Dec; 5(6):823-5. PubMed ID: 22103618 [TBL] [Abstract][Full Text] [Related]
35. Application of proteome analysis to the assessment of prognosis and response prediction in clinical oncology. Röcken C; Ketterlinus R; Ebert MP Curr Cancer Drug Targets; 2008 Mar; 8(2):141-5. PubMed ID: 18336197 [TBL] [Abstract][Full Text] [Related]
36. Precision oncology: where next? Gore M; Larkin J Lancet Oncol; 2015 Dec; 16(16):1593-5. PubMed ID: 26678189 [No Abstract] [Full Text] [Related]
37. [Translational research in clinical oncology: challenges and opportunities]. Díaz-Rubio García E An R Acad Nac Med (Madr); 2008; 125(1):105-20; discussion 121-2. PubMed ID: 18777846 [TBL] [Abstract][Full Text] [Related]
38. Abstracts of the 7th ESMO (European Society for Medical Oncology) Congress. 18-22 October 2002, Nice, France. Ann Oncol; 2002; 13 Suppl 5():1-200, I-LII. PubMed ID: 12474859 [No Abstract] [Full Text] [Related]
39. Introduction to special issue on biomarker-based clinical trial designs in oncology. Sargent DJ; Mandrekar S; Grothey A Chin Clin Oncol; 2015 Sep; 4(3):28. PubMed ID: 26408295 [No Abstract] [Full Text] [Related]
40. Translational molecular imaging for cancer. Pomper MG Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S16-26. PubMed ID: 16361132 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]